Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2507036 | 0.77 | TSHR (0.42) | — | |
| SCHEMBL29354050 | 0.77 | TSHR (0.42) | — | |
| SCHEMBL20740854 | 0.77 | KCNMA1 (0.40) | — | |
| Hydrochloric Acid SCHEMBL30943478 | 0.76 | TSHR (0.41) | — | |
| Phosphine SCHEMBL28247442 | 0.76 | TSHR (0.41) | — | |
| SCHEMBL27808614 | 0.76 | TSHR (0.41) | — | |
| SCHEMBL29930805 | 0.74 | MGLL (0.35) | — | |
| SCHEMBL20573774 | 0.74 | PKM (0.37) | GRM2 | |
| SCHEMBL29475365 | 0.74 | PKM (0.37) | GRM2 | |
| SCHEMBL28555388 | 0.72 | TSHR (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200138688-A1 | Composition For Enhancing Protein Strength | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2020-05-07 | — | — | US | claimed |
| US-11975091-B2 | Composition for enhancing protein strength | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2024-05-07 | — | — | US | disclosed |
| US-20210401714-A1 | Composition For Enhancing Protein Strength | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2021-12-30 | — | — | US | disclosed |
| US-20200138688-A1 | Composition For Enhancing Protein Strength | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2020-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210401714-A1 | Composition For Enhancing Protein Strength | CUTA, S100A4, S100A8 | GRM2 3869/4885 |
| US-11975091-B2 | Composition for enhancing protein strength | CUTA, S100A4, S100A8 | GRM2 3869/4885 |
| US-20200138688-A1 | Composition For Enhancing Protein Strength | CUTA, S100A4, S100A8 | GRM2 3869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.